STOCK TITAN

Enovis (NYSE:ENOV) 8-K announces Q2 earnings release, call

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Enovis Corporation (ENOV) filed a Form 8-K on 7 Aug 2025 to furnish Item 2.02 information. The filing states that a press release detailing Q2 FY25 results (quarter ended 4 Jul 2025) was issued the same day and is included as Exhibit 99.1. Management will host a conference call at 8:30 a.m. ET on 7 Aug 2025 to discuss those results. No financial figures, guidance, or qualitative commentary are provided within the 8-K itself. Exhibit 104 indicates the cover page is formatted in Inline XBRL.

The 8-K therefore serves solely as a procedural furnishing of the earnings release and does not, on its own, reveal performance metrics or forward-looking statements.

Positive

  • None.

Negative

  • None.

Insights

TL;DR – Routine 8-K furnishing Q2 earnings release; no numbers disclosed, neutral market impact.

The filing is administrative: it merely notifies investors that Enovis has published its second-quarter results via a separate press release (Exhibit 99.1) and scheduled a same-day call. Because actual revenue, EPS, margin, or guidance figures are absent, investors must reference the attached exhibit or call transcript for valuation insights. As such, the 8-K itself carries minimal standalone informational value and should not materially move the stock.

false00014208002025-08-07August 7, 202500014208002025-08-072025-08-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 7, 2025
 
Enovis Corporation
(Exact name of registrant as specified in its charter)
 
Delaware001-3404554-1887631
(State or other jurisdiction(Commission(I.R.S. Employer
of incorporation)File Number)Identification No.)

 2711 Centerville Road, Suite 400
Wilmington, DE 19808
(Address of Principal Executive Offices) (Zip Code)
 
(302) 252-9160
(Registrant's telephone number, including area code)


(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareENOVNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02. Results of Operations and Financial Condition.

On August 7, 2025, the Company issued a press release reporting financial results for the second quarter ended July 4, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into Item 2.02 of this report by reference. The Company has scheduled a conference call for 8:30 a.m. Eastern on August 7, 2025 to discuss its financial results.






Item 9.01. Financial Statements and Exhibits.

(d)    Exhibits

99.1 Enovis Corporation press release dated August 7, 2025, reporting financial results for the second quarter ended July 4, 2025.

104 Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:August 7, 2025
 Enovis Corporation
By:/s/ John Kleckner
Name: John Kleckner
Title:Vice President
Controller and Chief Accounting Officer
(Principal Accounting Officer)

FAQ

Why did Enovis (ENOV) file this Form 8-K?

To furnish its Q2 FY25 earnings press release under Item 2.02 and announce a conference call.

Does the 8-K include Enovis’ Q2 financial numbers?

No. The filing references Exhibit 99.1 for details, but the figures are not inside the core 8-K text.

When is the Enovis Q2 FY25 conference call?

7 Aug 2025 at 8:30 a.m. ET.

Which quarter is covered by the reported results?

The second quarter ended 4 Jul 2025.

What exchange does ENOV common stock trade on?

The New York Stock Exchange (NYSE).
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.39B
56.28M
1.57%
121.34%
12.07%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON